The Medtronic Guardian™ Connect System: A smart CGM!
Are you looking for a way to help outsmart your diabetes? Medtronic Guardian™ Connect CGM is the answer!
The Guardian™ Connect system is the first and only standalone Smart* Continuous Glucose Monitoring system that can predict high and low sensor glucose events up to 60 minutes in advance.
What Is the Guardian™ Connect System?
When using the Guardian™ Connect system you can:
See current glucose levels and trends at any time right on your smartphone
Get alerts – including predictive alerts up to 60 minutes in advance – of high and low glucose events*
Connect with care partners and healthcare professionals (HCPs) via the CareLink™ system platform
Access the Sugar.IQ™ diabetes assistant app for iOS users
The Guardian™ Connect system is the only CGM system with customizable predictive alerts that help you avoid both highs and lows. Using smart technology to predict where your glucose levels are headed, the system can alert you from 10 to 60 minutes before a high or low.
Exclusively available to patients using the Guardian™ Connect system, the Sugar.IQ™ diabetes assistant app (currently only available on iOS) analyzes how glucose levels react to food, exercise, and insulin. Together, the Guardian™ Connect system and the Sugar.IQ™ app turn hidden patterns into personalized insights that can help you make smarter diabetes decisions.1
Learn More about the Guardian ConnectApply Today
The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained using a home blood glucose meter and not on values provided by the system.
* Smart CGM predicts future high and low sensor glucose events up to 60 minutes in advance. Based on sensor glucose values with alerts turned on.
Important Safety Information: Guardian™ Connect CGM System
The Guardian™ Connect system requires a prescription and is indicated for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin, in patients (14 to 75 years of age) with diabetes mellitus. The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices, and is not recommended for people who are unwilling or unable to perform a minimum of two meter blood glucose tests per day, or for people who are unable or unwilling to maintain contact with their healthcare professional. The system requires a functioning mobile electronic device with correct settings. If the mobile device is not set up or used correctly, you may not receive sensor glucose information or alerts. For complete details of the system and its components, including warnings, contraindications, and precautions, please consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.
Important Safety Information: Sugar.IQ™ App
The Sugar.IQ™ app (MMT-8100) helps manage diabetes by facilitating the logging and display of meal entries and sensor glucose (SG) data, tracking meal log entries, reporting insights of how meals affect glucose levels, and supporting good choices and trends with motivational messages. The app serves as an additional display for real-time CGM data from the Guardian™ Connect system through the CareLink™ Personal software. It is not intended to provide medical advice and should not be relied upon for such purpose. The app is not intended to replace the real-time display of the CGM data on the Guardian™ Connect app, control any functions of the connecting device, calculate insulin or other drug doses, or modify date or control functions of the Guardian™ Connect system. All therapy decisions should be made by the app user based on blood glucose (BG) measurements obtained from a BG meter. Changes to treatment should only be made in consultation with a healthcare professional (HCP). For complete details, consult the user guide at http://www.medtronicdiabetes.com/support/download-library/user-guides and important safety information.
The system is intended to complement, not replace, information obtained from standard blood glucose monitoring devices. All therapy adjustments should be based on measurements obtained from standard blood glucose monitoring devices and not on values provided by the system.
Important Safety Information: CareLink™ Software
The CareLink™ software is intended for use as a tool to help manage diabetes. The purpose of the software is to take information transmitted from insulin pumps, glucose meters and continuous glucose monitoring systems, and turn it into CareLink™ reports. The reports provide information that can be used to identify trends and track daily activities—such as carbohydrates consumed, meal times, insulin delivery, and glucose readings. NOTE: CareLink™ report data is intended for use as an adjunct in the management of diabetes only and NOT intended to be relied upon by itself. Patients should consult their healthcare providers familiar with the management of diabetes prior to making changes in treatment. For more details, please consult important safety information. and the appropriate CareLink™ User Guide at http://www.medtronicdiabetes.com/support/download-library/user-guides.
Tags: CGM, Continuous Glucose Monitors, Diabetes, Diabetes Management